Editorial: Real-world experience with CFTR modulator therapy

Front Pharmacol. 2023 Nov 14:14:1331829. doi: 10.3389/fphar.2023.1331829. eCollection 2023.

Authors

Burkhard Tümmler^{1

2}, Pierre-Régis Burgel^{3

4}

Affiliations

¹ Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.
² Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany.
³ Université Paris Cité, Institut Cochin, Inserm U1016, Paris, France.
⁴ Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

No abstract available

Keywords: CFTR; cystic fibrosis; elexacaftor; ivacaftor; tezacaftor.

Publication types

Editorial